| For: | Abdalla MMI. Gut-liver axis in diabetes: Mechanisms and therapeutic opportunities. World J Gastroenterol 2025; 31(29): 109090 [PMID: 40809928 DOI: 10.3748/wjg.v31.i29.109090] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v31/i29/109090.htm |
| Number | Citing Articles |
| 1 |
志君 李. Association between Metabolic Dysfunction-Related Fatty Liver Disease (MASLD) and Colorectal Cancer: A Comprehensive Review of Diagnosis and Disease Progression. Advances in Clinical Medicine 2026; 16(02) doi: 10.12677/acm.2026.162527
|
| 2 |
Un Ju Jung, Sang Ryong Kim. Brown Seaweeds and Their Bioactive Compounds in Type 2 Diabetes: Mechanisms Underlying Metabolic Regulation. International Journal of Molecular Sciences 2026; 27(11) doi: 10.3390/ijms27114753
|
| 3 |
The bidirectional relationship between diabetes mellitus and liver disease: Mechanisms, clinical implications, and management strategies. Endocrine 2026; 91(1) doi: 10.1007/s12020-026-04561-3
|
| 4 |
Asmaa.F. Khafaga, Hassan A. Rudayni, Nourhan E. Khalifa, Abdullah S. Alawam, Ahmed A. Allam, Ayman E. Taha, Mohammed A.E. Naiel, Mohamed E. Abd El-Hack. The gut–liver axis in chronic liver diseases: An integrative immunopathological perspective bridging animal models and human evidence. Tissue and Cell 2026; 101 doi: 10.1016/j.tice.2026.103456
|
| 5 |
Yao Chen, Dandan Ma, Qiuming Chen, Maomao Zeng, Jie Chen, Zhiyong He. Beneficial Effects of Gegen Qinlian Decoction and Its Food–Medicine Homologous Alternative Formulas Against Type 2 Diabetes Mellitus: Insights from Multi-Omics Analysis. Pharmaceuticals 2026; 19(4) doi: 10.3390/ph19040530
|
| 6 |
Gaoli Zhou, Ronge Xing, Zongji Wang, Rongfeng Li, Song Liu, Hang Li, Guantian Li. Chitosan and chito-oligosaccharides as multifunctional therapeutics for metabolic dysfunction-associated steatotic liver disease (MASLD). Carbohydrate Polymers 2026; 375 doi: 10.1016/j.carbpol.2025.124737
|
| 7 |
Yu Zhang, Dong D. Wang. Gut microbiome in type 2 diabetes: insights from metagenomics, multi-omics, and diet–microbe interactions. Gut Microbes 2026; 18(1) doi: 10.1080/19490976.2026.2644682
|
| 8 |
Francesca Uberti, Simone Mulè, Francesca Parini, Matteo Musu, Rebecca Galla. Natural Extract Combination Modulates Intestinal Barrier and Hepatic Cholesterol via the Gut–Liver Axis In Vitro. Pharmaceutics 2026; 18(3) doi: 10.3390/pharmaceutics18030328
|
| 9 |
Caroline Woelffel Silva, Eliot M.Dugan, Melissa Huang, Danúbia Joanes Rosa Guerra, Geniana da Silva Gomes, Tiago Antônio de Oliveira Mendes, Frederico Augusto Ribeiro de Barros, Elad Tako. Macauba (Acrocomia aculeata) kernel-derived protein hydrolysates modulate intestinal development, antioxidant responses and hepatic metabolic gene expression in an in ovo (Gallus gallus) model. Food Research International 2026; 241 doi: 10.1016/j.foodres.2026.119758
|
| 10 |
Iliyana Sazdova, Hristo Gagov, Nikola Hadzi-Petrushev, Marina Konaktchieva, Rossitza Konakchieva, Mitko Mladenov. Advanced Studies in Molecular and Metabolic Mechanisms of Diabetes: Pathogenic Crosstalk, Biomarkers, and Translational Therapeutics. Applied Sciences 2026; 16(6) doi: 10.3390/app16063027
|
| 11 |
Da-Yeon Lee, Jing Liu, Gopal Lamichhane, Ashton Swayze, Guolong Zhang, Tae Young Kim, Josephine M. Egan, Yoo Kim. Fermented Red Ginseng Restores Age-Associated Insulin Homeostasis and Gut Microbiome Balance in Mice. Biology 2026; 15(3) doi: 10.3390/biology15030211
|
| 12 |
Almir Fajkić, Yun Wah Lam, Rijad Jahić, Ivan Ćavar, Antonio Markotić, Andrej Belančić. From Adipose Dysfunction to Multi-Organ Steatosis: Defining the Metabolic Steatotic Axis. Current Issues in Molecular Biology 2026; 48(2) doi: 10.3390/cimb48020178
|
| 13 |
You Wang, Lijia Wu, Xincui Bao, Jing Yang, Miao Xu, Yuzhuo Chang, Zhe Liu, Lingling Qin, Ming Gao, Cuiyan Lv, Tonghua Liu. Lipid metabolic dysregulation in diabetic kidney disease: mechanisms, cellular impact, and therapeutic strategies. Journal of Clinical & Translational Endocrinology 2026; 44 doi: 10.1016/j.jcte.2026.100436
|